A director at Svi Public Company Limited bought 500,000 shares at 8.490THB and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
SVI (TH), a company active in the Electrical Components & Equipment industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 3 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date November 9, 2021, the closing p...
GREATER CHINA Sector Property: Rock-bottom sentiment and policy headwinds suppressing valuations. Update Innovent Biologics, Inc (1801 HK/BUY/HK$76.00/Target: HK$95.00): Transforming into global innovator. INDONESIA Sector Banking: Various corporate actions to support growth. MALAYSIA Sector Gaming: Reopening of RWG and restoration of interstate travel in October to accelerate earnings recovery of casino subsector. Maintain OVERWEIGHT. Update VS Industry (VSI MK/BUY/RM1.56/Target: RM1.86): VS ...
Management maintains their revenue guidance for 2021 and expects core profit to grow 46% hoh in 2H21. Despite the continuing raw materials shortage in 2H21, we believe SVI would suffer limited impact as the company can pass on the cost hikes to most of their customers. Moreover, the positives of strong sales backlogs and our expectation of a baht depreciation could support the company’s earnings in 2H21. We roll over our valuation to 2022 and maintain BUY with a higher target price of Bt6.45.
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
KEY HIGHLIGHTS Results Bangchak Petroleum (BCP TB/HOLD/Bt26.00/Target: Bt30.00) 1Q21: Slim core profit as expected. CP ALL (CPALL TB/HOLD/Bt60.75/Target: Bt65.00) 1Q21: Disappointing results; downgrade to HOLD. Electricity Generating (EGCO TB/BUY/Bt175.00/Target: Bt242.00) 1Q21: Results in line; positive outlook. PTT Global Chemical (PTTGC TB/BUY/Bt67.25/Target: Bt75.00) 1Q21: Result was 10% higher than consensus; 2Q21 earnings expected to be this year’s quarterly peak. Star Petroleum Refin...
GREATER CHINA Sector Automobile: Weekly: Share price weakness from chip shortage provides buying opportunity. Maintain MARKET WEIGHT. Top picks: BYD, CATL, Zhongsheng and Yongda. Healthcare: Possible impact from COVID-19 vaccine patent waiver. Results Budweiser APAC (1876 HK/BUY/HK$25.50/Target: HK$29.20): 1Q21: Strong recovery driven by China market. Upgrade to BUY. INDONESIA Sector Plantation: Potential revision of Indonesia’s palm oil export levy would give an earnings boost to upstream oper...
REGIONAL Sector Plantation: Palm oil is pricing itself out of the Indian market as its selling price is now very close to those of mustard oil and rice bran oil. Demand is switching to the latter. GREATER CHINA Results A-Living Smart City Services (3319 HK/BUY/HK$31.40/Target: HK$44.41): 2020: In line with expectations; management guides 3-year CAGR of 40%. China Merchants Bank (3968 HK/BUY/HK$63.20/Target: HK$71.00): 2020: Results in line; sluggish profit growth due to rising operating costs. ...
GREATER CHINA Initiate Coverage Biotech Sector: Building competence for going global. Results Alibaba Group (BABA US/BUY/US$264.69/Target: US$355.00): 3QFY21: Solid results, continued investment to gain market share moving forward. INDONESIA Strategy Alpha Picks: Adding UNTR, WIKA and WSKT: We add UNTR, WIKA and WSKT; our picks: UNTR, BBNI, BMRI, KLBF, WIKA, WSKT, BSDE and SMRA. MALAYSIA Results Bursa Malaysia (BURSA MK/HOLD/RM9.35/Target: RM9.10): 4Q20 earnings came in within our expectations...
KEY HIGHLIGHTS Strategy Alpha Picks: February Portfolio Markets pause after strong rally; cut losses on EGCO. Update MK Restaurant Group (M TB/BUY/Bt50.00/Target: Bt61.50) 4Q20 earnings to drop both yoy and qoq. SVI (SVI TB/BUY/Bt5.55/Target: Bt5.80) 4Q20 results preview: Laggard stock; reiterate BUY.
GREATER CHINA Economics Money Supply: New corporate loans fell; yoy total credit growth remained strong. Sector Internet: Draft anti-monopoly rules for digital economy to promote sustainable development. Machinery: Excavator sales up 61% yoy in Oct 20; 2021 outlook remains positive. Update Jiumaojiu International Holdings (9922 HK/BUY/HK$17.08/Target: HK$21.36): New store openings of Tai Er exceed target. INDONESIA Update Pembangunan Perumahan (PTPP IJ/BUY/Rp1,020/Target: Rp1,400): Higher burn ...
KEY HIGHLIGHTS Results Bangkok Dusit Medical Services (BDMS TB/BUY/Bt21.00/Target: Bt26.00) 3Q20: Despite revenue and core profit falling yoy, core profit was better than forecasted on effective cost control. SVI (SVI TB/BUY/Bt4.54/Target: Bt5.60) 3Q20: Strong earnings momentum. Update Bumrungrad Hospital (BH TB/SELL/Bt109.00/Target: Bt80.00) Expect core profits to continue to fall in the next two quarters. KCE Electronics (KCE TB/BUY/Bt35.50/Target: Bt53.00) Huge turnaround expected; upg...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.